Analytical Best Practices for Raw Materials Testing
The testing of raw materials is essential as raw material quality determines the outcome of biologic product quality.
Because the raw materials used in biologic drug development can impact drug interaction and patient safety, the testing of raw materials is necessary to ensure quality. Pharmaceutical Technologyspoke with Roisin Browne, site manager at Almac Sciences’ analytical services site in Athlone, Ireland; Andrew Bulpin, head of Process Solutions at MilliporeSigma; and Erik Foehr, PhD, vice-president, Analytical Sciences, at Pacific BioLabs to discuss best practices for analytical testing techniques and instrumentation used for raw materials testing.
Read this article in Pharmaceutical Technology’s Bio/Pharma Laboratory Best Practices 2018 eBook.
Article Details
Pharmaceutical Technology
eBook: Bio/Pharma Laboratory Best Practices 2018
Vol. 42
November 2018
Pages: 38–41
Citation
When referring to this article, please cite it as F. Mirasol, "Analytical Best Practices for Raw Materials Testing," Pharmaceutical Technology Bio/Pharma Laboratory Best Practices eBook (November 2018).
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
